Mobile Investor

 Stock Information
CLDX (NASDAQ)
Last Price: 2.98
Last Trade: 4:00 PM ET - Dec 13, 2017
Change: 0.00   (0.00%)
Open: 0.00
Close: 2.98
High: N/A
Low: N/A
52-Week High: 4.07
52-Week Low: 2.20
Volume: N/A
Stock price graph
 Recent News
Nov 30, 2017
Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors
Nov 17, 2017
Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma
Nov 7, 2017
Celldex Reports Third Quarter 2017 Results
Oct 3, 2017
Celldex Therapeutics Appoints Margo Heath-Chiozzi, M.D., as Senior Vice President, Regulatory Affairs
Sep 22, 2017
Celldex Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
 Events & Presentations
Mar 4, 2015 - 8:40 AM ET
Cowen and Company 35th Annual Health Care Conference
Feb 24, 2015 - 8:00 AM ET
Celldex Therapeutics 2014 Year End Financial Results
Feb 12, 2015 - 10:20 AM ET
2015 Leerink Global Healthcare Conference
Nov 4, 2014 - 4:00 PM
Celldex Therapeutics Third Quarter Business and Financial Highlights Press Release Issued
Sep 8, 2014 - 1:25 PM ET
Morgan Stanley Healthcare Conference
 Financial Filings
Nov 7, 2017
Form 10-Q - Celldex Therapeutics, Inc.
Aug 8, 2017
Form 10-Q - Celldex Therapeutics, Inc.
May 9, 2017
Form 10-Q - Celldex Therapeutics, Inc.
Apr 28, 2017
Form DEF 14A - Celldex Therapeutics, Inc.
Apr 17, 2017
Form PRE 14A - Celldex Therapeutics, Inc.
Mar 14, 2017
Form 10-K - Celldex Therapeutics, Inc.
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2017 Celldex Therapeutics, Inc.